Research and Development

Novartis has reiterated its expectation of sales growth beginning in 2018, as well as a positive outlook for its Alcon …

We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new …

Pfizer Senior Vice President of Medicinal Sciences, Tony Wood, has agreed to join GSK, as broken by FierceBiotech. The appointment …

Many previous studies have shown that statins are able to have an impact on cancer cells but the results have …

The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …

Releasing 20 million mosquitoes does not sound like the right way to go about reducing the overall population; however, the …

Only a short while after leaving his position as CEO of GSK, it seems Andrew Witty cannot resist getting back …

As the week comes to a close, we bring you the stories that were most read by our readers – …

Scientists from the University of Oxford have developed a heart scan that can identify inflammation around arteries that can suggest …

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …

In what could well be a game-changing decision for cancer treatment, the FDA advisory panel gave Novartis’ CAR-T Therapy, CTL019 …

Enterome, a clinical-stage company specialising in the personalised treatment of microbiome-related diseases based in Paris, France, has announced the appointment …

Nabriva Therapeutics, a pharmaceutical company that is developing new antibiotics for the treatment of serious infections, has brought Francesco Maria …

Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …

Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …